These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 19777235)

  • 1. The -283C/T polymorphism of the DNMT3B gene influences the progression of joint destruction in rheumatoid arthritis.
    Nam EJ; Kim KH; Han SW; Cho CM; Lee J; Park JY; Kang YM
    Rheumatol Int; 2010 Aug; 30(10):1299-303. PubMed ID: 19777235
    [TBL] [Abstract][Full Text] [Related]  

  • 2. FCRL3 gene polymorphisms contribute to the radiographic severity rather than susceptibility of rheumatoid arthritis.
    Han SW; Sa KH; Kim SI; Lee SI; Park YW; Lee SS; Yoo WH; Kang JY; Soe JS; Nam EJ; Lee J; Park JY; Kang YM
    Hum Immunol; 2012 May; 73(5):537-42. PubMed ID: 22386693
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of a single-nucleotide polymorphism in CD40 with the rate of joint destruction in rheumatoid arthritis.
    van der Linden MP; Feitsma AL; le Cessie S; Kern M; Olsson LM; Raychaudhuri S; Begovich AB; Chang M; Catanese JJ; Kurreeman FA; van Nies J; van der Heijde DM; Gregersen PK; Huizinga TW; Toes RE; van der Helm-Van Mil AH
    Arthritis Rheum; 2009 Aug; 60(8):2242-7. PubMed ID: 19644859
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic studies on components of the Wnt signalling pathway and the severity of joint destruction in rheumatoid arthritis.
    de Rooy DP; Yeremenko NG; Wilson AG; Knevel R; Lindqvist E; Saxne T; Krabben A; Leijsma MK; Daha NA; Tsonaka S; Zhernakova A; Houwing-Duistermaat JJ; Huizinga TW; Toes RE; Baeten DL; Brouwer E; van der Helm-van Mil AH
    Ann Rheum Dis; 2013 May; 72(5):769-75. PubMed ID: 23041840
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of polymorphisms of HLA-DRB1 and TNF-308 G/A with radiographic joint damage in patients with early rheumatoid arthritis with high inflammatory activity, treated according to the principle of "Treat to target" (REMARKA study).
    Guseva IA; Smirnov AV; Demidova NV; Krylov MY; Avdeeva AS; Samarkina EY; Luchikhina EL; Karateev DE; Abramov DD; Nasonov EL
    Ter Arkh; 2018 May; 90(5):38-43. PubMed ID: 30701887
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A genetic variant in granzyme B is associated with progression of joint destruction in rheumatoid arthritis.
    Knevel R; Krabben A; Wilson AG; Brouwer E; Leijsma MK; Lindqvist E; de Rooy DP; Daha NA; van der Linden MP; Tsonaka S; Zhernakova A; Westra HJ; Franke L; Houwing-Duistermaat JJ; Toes RE; Huizinga TW; Saxne T; van der Helm-van Mil AH
    Arthritis Rheum; 2013 Mar; 65(3):582-9. PubMed ID: 23440692
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CCR5 gene polymorphism is a genetic risk factor for radiographic severity of rheumatoid arthritis.
    Han SW; Sa KH; Kim SI; Lee SI; Park YW; Lee SS; Yoo WH; Soe JS; Nam EJ; Lee J; Park JY; Kang YM
    Tissue Antigens; 2012 Nov; 80(5):416-23. PubMed ID: 22924548
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interaction between TGF-β1 (869C/T) polymorphism and biochemical risk factor for prediction of disease progression in rheumatoid arthritis.
    Hussein YM; Mohamed RH; El-Shahawy EE; Alzahrani SS
    Gene; 2014 Feb; 536(2):393-7. PubMed ID: 24315820
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A genetic variant in the region of MMP-9 is associated with serum levels and progression of joint damage in rheumatoid arthritis.
    de Rooy DP; Zhernakova A; Tsonaka R; Willemze A; Kurreeman BA; Trynka G; van Toorn L; Toes RE; Huizinga TW; Houwing-Duistermaat JJ; Gregersen PK; van der Helm-van Mil AH
    Ann Rheum Dis; 2014 Jun; 73(6):1163-9. PubMed ID: 23696630
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of matrix metalloproteinase-3 functional SNP on serum matrix metalloproteinase-3 level and outcome measures in Japanese RA patients.
    Tsukahara S; Shinozaki M; Ikari K; Mochizuki T; Inoue E; Tomatsu T; Hara M; Yamanaka H; Kamatani N; Momohara S
    Rheumatology (Oxford); 2008 Jan; 47(1):41-4. PubMed ID: 18077489
    [TBL] [Abstract][Full Text] [Related]  

  • 11. FCRL3 promoter 169 CC homozygosity is associated with susceptibility to rheumatoid arthritis in Dutch Caucasians.
    Thabet MM; Wesoly J; Slagboom PE; Toes RE; Huizinga TW
    Ann Rheum Dis; 2007 Jun; 66(6):803-6. PubMed ID: 17179172
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of the -2849 interleukin-10 promoter polymorphism with autoantibody production and joint destruction in rheumatoid arthritis.
    Lard LR; van Gaalen FA; Schonkeren JJ; Pieterman EJ; Stoeken G; Vos K; Nelissen RG; Westendorp RG; Hoeben RC; Breedveld FC; Toes RE; Huizinga TW
    Arthritis Rheum; 2003 Jul; 48(7):1841-8. PubMed ID: 12847677
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Matrix metalloproteinase gene polymorphisms in patients with rheumatoid arthritis.
    Scherer S; de Souza TB; de Paoli J; Brenol CV; Xavier RM; Brenol JC; Chies JA; Simon D
    Rheumatol Int; 2010 Jan; 30(3):369-73. PubMed ID: 19504098
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The extrapituitary prolactin promoter polymorphism is associated with rheumatoid arthritis and anti-CCP antibodies in Mexican population.
    Reyes-Castillo Z; Pereira-Suárez AL; Palafox-Sanchez CA; Rangel-Villalobos H; Estrada-Chávez C; Oregón-Romero E; Angel-Chávez LI; Muñoz-Barrios S; Bueno-Topete MR; Muñoz-Valle JF
    Gene; 2013 Aug; 525(1):130-5. PubMed ID: 23660301
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic Factors for the Severity of ACPA-negative Rheumatoid Arthritis in 2 Cohorts of Early Disease: A Genome-wide Study.
    de Rooy DP; Tsonaka R; Andersson ML; Forslind K; Zhernakova A; Frank-Bertoncelj M; de Kovel CG; Koeleman BP; van der Heijde DM; Huizinga TW; Toes RE; Houwing-Duistermaat JJ; Ospelt C; Svensson B; van der Helm-van Mil AH
    J Rheumatol; 2015 Aug; 42(8):1383-91. PubMed ID: 26077402
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic predisposition of the severity of joint destruction in rheumatoid arthritis: a population-based study.
    Knevel R; Gröndal G; Huizinga TW; Visser AW; Jónsson H; Víkingsson A; Geirsson AJ; Steinsson K; van der Helm-van Mil AH
    Ann Rheum Dis; 2012 May; 71(5):707-9. PubMed ID: 22219137
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of chondromodulin-II Val58Ile polymorphism with radiographic joint destruction in rheumatoid arthritis.
    Graessler J; Verlohren M; Graessler A; Zeissig A; Kuhlisch E; Kopprasch S; Schroeder HE
    J Rheumatol; 2005 Sep; 32(9):1654-61. PubMed ID: 16142856
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of the TNF +489 polymorphism with susceptibility and radiographic damage in rheumatoid arthritis.
    van Krugten MV; Huizinga TW; Kaijzel EL; Zanelli E; Drossaers-Bakker KW; van de Linde P; Hazes JM; Zwinderman AH; Breedveld FC; Verweij CL
    Genes Immun; 1999 Nov; 1(2):91-6. PubMed ID: 11196668
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The -590 IL-4 promoter polymorphism in patients with rheumatoid arthritis.
    Pawlik A; Wrzesniewska J; Florczak M; Gawronska-Szklarz B; Herczynska M
    Rheumatol Int; 2005 Nov; 26(1):48-51. PubMed ID: 15660235
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytotoxic T-lymphocyte-associated protein 4 gene polymorphism is related to rheumatoid arthritis in Egyptian population.
    Fattah SA; Ghattas MH; Saleh SM; Abo-Elmatty DM
    Arch Physiol Biochem; 2017 Feb; 123(1):50-53. PubMed ID: 27808571
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.